BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2141511)

  • 41. [Prognosis of surgically treated colorectal neoplasms. Contribution of multivariate analysis].
    Huguier M; Rey C; Chastang C; Houry S; Lacaine F
    Gastroenterol Clin Biol; 1989 May; 13(5):463-8. PubMed ID: 2753282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
    Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
    Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer.
    Werther K; Christensen IJ; Nielsen HJ;
    Eur J Surg; 2001 Apr; 167(4):287-92. PubMed ID: 11354321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of perioperative blood transfusions on survival of patients after radical surgery for colorectal cancer.
    Leite JF; Granjo ME; Martins MI; Reis RC; Monteiro JC; Castro-Sousa F
    Int J Colorectal Dis; 1993 Sep; 8(3):129-33. PubMed ID: 8245667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of blood transfusions on tumor recurrence and survival rate in colorectal carcinoma.
    Liewald F; Wirsching RP; Zülke C; Demmel N; Mempel W
    Eur J Cancer; 1990 Mar; 26(3):327-35. PubMed ID: 2141490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
    Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
    Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
    Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
    Mynster T; Christensen IJ; Moesgaard F; Nielsen HJ
    Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of surgery outcome for colorectal carcinoma in the United Arab Emirates.
    el-Ghazawy IM; Bener A; Saad el-Din SS; Abou Azab I; Siddiqui M
    East Mediterr Health J; 2001; 7(1-2):221-8. PubMed ID: 12596973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
    Ganesh S; Sier CF; Heerding MM; van Krieken JH; Griffioen G; Welvaart K; van de Velde CJ; Verheijen JH; Lamers CB; Verspaget HW
    Br J Cancer; 1997; 75(12):1793-801. PubMed ID: 9192984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation of the number of metastatic lymph nodes in dukes' C colorectal cancer.
    Fukushima T; Akagi Y; Murakami H; Ushijima M; Ogata Y; Shirouzu K; Murotani K
    Anticancer Res; 2013 Jul; 33(7):2949-55. PubMed ID: 23780985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic blood transfusion in patients in Dukes B stage of colorectal cancer.
    Zdravkovic D; Bilanovic D; Randjelovic T; Granic M; Djukanovic B; Ivanovic N; Dikic S; Nikolic D; Zdravkovic M; Soldatovic I
    Med Oncol; 2011 Mar; 28(1):170-4. PubMed ID: 20151229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma.
    Meguerditchian AN; Bairati I; Lagacé R; Harel F; Kibrité A
    Am J Surg; 2005 Jun; 189(6):707-13. PubMed ID: 15910724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Large bowel cancer: the effect of perioperative blood transfusion on outcome.
    Cheslyn-Curtis S; Fielding LP; Hittinger R; Fry JS; Phillips RK
    Ann R Coll Surg Engl; 1990 Jan; 72(1):53-9. PubMed ID: 2405765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathological features of serrated adenocarcinoma defined by Mäkinen in dukes' B colorectal carcinoma.
    Shida Y; Fujimori T; Tanaka H; Fujimori Y; Kimura R; Ueda H; Ichikawa K; Tomita S; Nagata H; Kubota K; Tsubaki M; Kato H; Yao T; Sugai T; Sugihara K; Ohkura Y; Imura J
    Pathobiology; 2012; 79(4):169-74. PubMed ID: 22433973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
    Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
    Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perioperative blood transfusion increases the risk of recurrence in colorectal cancer.
    Beynon J; Davies PW; Billings PJ; Channer JL; Protheroe D; Umpleby HC; Mortensen NJ; Williamson RC
    Dis Colon Rectum; 1989 Nov; 32(11):975-9. PubMed ID: 2806027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.